CH618849A5 - - Google Patents

Download PDF

Info

Publication number
CH618849A5
CH618849A5 CH393976A CH393976A CH618849A5 CH 618849 A5 CH618849 A5 CH 618849A5 CH 393976 A CH393976 A CH 393976A CH 393976 A CH393976 A CH 393976A CH 618849 A5 CH618849 A5 CH 618849A5
Authority
CH
Switzerland
Prior art keywords
tryptophan
proline
acyl
solution
acetyl
Prior art date
Application number
CH393976A
Other languages
German (de)
English (en)
Inventor
Mitsuo Aoki
Kazuhiko Watanabe
Shunichi Murase
Isao Hiraoka
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of CH618849A5 publication Critical patent/CH618849A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Indole Compounds (AREA)
  • Pyrrole Compounds (AREA)
CH393976A 1975-04-01 1976-03-30 CH618849A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP50040072A JPS51115909A (en) 1975-04-01 1975-04-01 A process for preparing amino acid parenteral injection mixed with a r educing sugar

Publications (1)

Publication Number Publication Date
CH618849A5 true CH618849A5 (fr) 1980-08-29

Family

ID=12570712

Family Applications (1)

Application Number Title Priority Date Filing Date
CH393976A CH618849A5 (fr) 1975-04-01 1976-03-30

Country Status (11)

Country Link
US (1) US4085207A (fr)
JP (1) JPS51115909A (fr)
BE (1) BE840227A (fr)
CA (1) CA1052699A (fr)
CH (1) CH618849A5 (fr)
DE (1) DE2614092B2 (fr)
ES (1) ES446895A1 (fr)
FR (1) FR2305977A1 (fr)
GB (1) GB1477624A (fr)
NL (1) NL184148C (fr)
SE (1) SE440451B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4210637A (en) * 1978-07-31 1980-07-01 Massachusetts Institute Of Technology Composition and method for suppressing appetite for calories as carbohydrates
JPS5536457A (en) * 1978-09-08 1980-03-14 Ajinomoto Co Inc Amino acid infusion
CA1257131A (fr) * 1984-07-27 1989-07-11 John Y. Park Compose pour nutrition parenterale et enterale totale
GB8500862D0 (en) * 1985-01-14 1985-02-20 Tate & Lyle Plc Composition
US4639465A (en) * 1985-08-30 1987-01-27 Commonwealth Medical Corporation Of America Method and composition for relieving pain
DE3601398A1 (de) * 1986-01-18 1987-07-23 Fresenius Ag Verwendung von oligopeptiden zur behandlung von cerebralen stoerungen
JPH0435507U (fr) * 1990-07-20 1992-03-25
EP1249235B1 (fr) * 2000-01-18 2006-08-02 Ajinomoto Co., Inc. Remedes contre l'hepatite contenant de l'alanine et de la glycine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2411897A (en) * 1943-01-02 1946-12-03 Sterling Drug Inc Pharmaceutical solution
DE1024325B (de) * 1952-10-31 1958-02-13 Colgate Palmolive Co Verfahren zum Konservieren von Lebensmitteln
US3080234A (en) * 1960-12-06 1963-03-05 Pfizer & Co C Method of improving the efficiency of amino acid diets
US3697287A (en) * 1969-01-28 1972-10-10 Morton Norwich Products Inc Amino acid food composition

Also Published As

Publication number Publication date
ES446895A1 (es) 1977-10-01
FR2305977A1 (fr) 1976-10-29
NL7603426A (nl) 1976-10-05
SE440451B (sv) 1985-08-05
NL184148C (nl) 1989-05-01
AU1247376A (en) 1977-10-06
CA1052699A (fr) 1979-04-17
NL184148B (nl) 1988-12-01
SE7603837L (sv) 1976-10-02
GB1477624A (en) 1977-06-22
BE840227A (fr) 1976-07-16
JPS5624647B2 (fr) 1981-06-08
JPS51115909A (en) 1976-10-13
DE2614092A1 (de) 1976-10-14
FR2305977B1 (fr) 1978-09-01
US4085207A (en) 1978-04-18
DE2614092B2 (de) 1978-02-23

Similar Documents

Publication Publication Date Title
DE68905387T2 (de) Aminosäure-Nahrungsmittelzusammensetzungen.
DE2310791A1 (de) Diaetmischungen zur behandlung des uebergewichtes bei menschen
DE2556100A1 (de) Aminosaeurepraeparate fuer leberkranke patienten
DE2726969A1 (de) Kalorienarmes produkt vom majonaise- und dressing-typ sowie verfahren zu dessen herstellung
AT395111B (de) Verfahren zur herstellung von infusionsloesungen zur pareuteralen ernaehrung
DE69232957T2 (de) Mit flüssigen Infusionen gefüllte Behälter
DE69521766T2 (de) Wasserlösliche Vitamin B enthaltende Lösungen zur totaler parenteraler Ernährung
DE2936236A1 (de) Aminosaeureloesung fuer die intravenoese ernaehrung
DE3151245A1 (de) Zur enteralen ernaehrung geeignete nahrungszusammensetzung
CH618849A5 (fr)
EP0399341B1 (fr) Composition aqueuse pour l'alimentation parentérale
DE2945790A1 (de) Neutrales kristallines salz einer basischen l-aminosaeure mit l-apfelsaeure und verfahren zu dessen herstellung
DE2357119A1 (de) Verfahren zur herstellung eines stabilen konzentrats mit einem hohen gehalt an essentiellen biofaktoren
DE68910126T2 (de) Nahrungsmittelzusammensetzung.
DE69929128T2 (de) Nährstoffinfusionspräparat
DE2164170C3 (de) Verfahren zur biotechnischen Herstellung von L-Arginin
DE4134723C1 (fr)
DE2642768C2 (fr)
DE2750159C3 (de) Infusionslösung zur Behandlung von hepatischer Encephalopathie und ein Verfahren zu deren Herstellung
DE2140084B2 (de) Verwendung von Maltose-Lösungen
DE2531204A1 (de) L-aminosaeuregemische fuer parenterale oder orale anwendung
DE2108404C3 (de) Verfahren zur Erzeugung von L-Arginin durch Mikroorganismen
DE2829036A1 (de) Verfahren zur herstellung von bilanzierter, synthetischer diaetmischung in fluessiger form
AT394135B (de) Waessrige aminosaeureloesung fuer die parenterale ernaehrung
DE1934317B1 (de) Verfahren zur Herstellung stabiler,nicht pyrogener,intravenoes applizierbarer,waessriger aminosaeurehaltiger Fettemulsionen

Legal Events

Date Code Title Description
PL Patent ceased